1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
75.67%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
139.12%
Gross profit growth above 1.5x MAXN's 73.39%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
505.40%
EBIT growth above 1.5x MAXN's 71.83%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
616.64%
Operating income growth above 1.5x MAXN's 66.50%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
320.55%
Net income growth above 1.5x MAXN's 73.10%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
329.17%
EPS growth of 329.17% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
315.00%
Diluted EPS growth above 1.5x MAXN's 73.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.14%
Share change of 0.14% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-1.82%
Reduced diluted shares while MAXN is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
477.41%
OCF growth above 1.5x MAXN's 93.92%. David Dodd would confirm a clear edge in underlying cash generation.
156.59%
FCF growth above 1.5x MAXN's 91.23%. David Dodd would verify if the firm’s strategic investments yield superior returns.
10938.99%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
53.87%
Positive 5Y CAGR while MAXN is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
53.69%
3Y revenue/share CAGR above 1.5x MAXN's 7.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4077.42%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
-4.71%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-32.03%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
821.32%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
10067.98%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
220.60%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-19.49%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-10.49%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.06%
Our AR growth while MAXN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.77%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.43%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
10.92%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
7.10%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
31.43%
R&D growth drastically higher vs. MAXN's 3.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.93%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.